Latest news
Exposed to COVID-19? A new drug may keep the infection away. Here’s how it works - PolitiFactPolitiFact · Mon, 10 Aug 2026 19:32:28 GMTShionogi (TSE:4507) Starts U.S. XOCOVA Sales As Strong Q1 Results Put Valuation In Focus - simplywall.stsimplywall.st · Fri, 07 Aug 2026 02:57:07 GMTFDA approves new drug to help stop COVID-19 infection after exposure - WBAL-TVWBAL-TV · Tue, 04 Aug 2026 20:48:00 GMTShionogi makes the call on COVID pill Xocova TV spot - Fierce PharmaFierce Pharma · Thu, 30 Jul 2026 07:00:00 GMTNew prescription pill aims to help prevent COVID after exposure - KPBSKPBS · Thu, 30 Jul 2026 07:00:00 GMTShionogi (TSE:4507) Is Up 6.5% After U.S. Launch Of XOCOVA COVID Prophylaxis Drug – Has The Bull Case Changed? - simplywall.stsimplywall.st · Thu, 30 Jul 2026 07:00:00 GMTShionogi’s Xocova now available in USA - The Pharma LetterThe Pharma Letter · Wed, 29 Jul 2026 12:23:39 GMTOral Antiviral Xocova Available for COVID-19 Postexposure Prophylaxis - Renal and Urology NewsRenal and Urology News · Wed, 29 Jul 2026 07:00:00 GMT